Viable microorganisms
A sterility result concerns the tested sample and procedure. It does not guarantee that every unit remains uncontaminated after testing.
Analytical scope · C-024
What peptide tests can and cannot prove
Match the test to the attribute. Identity, purity, quantity, sterility, endotoxin and contaminants are different questions. A result supports only the measurand, sample and conditions covered by the procedure.
A peptide test can support a defined claim only when the analytical procedure is suitable for that intended purpose and the reported result applies to the relevant sample. Purity does not establish identity. Identity does not establish quantity. Neither establishes sterility, endotoxin status, clinical safety or what is inside an unlinked vial.
Read every result as a sentence with four parts: this method measured this attribute in this sample within these limits. If one part is missing, the conclusion needs a qualification.
Attribute-by-method matrix
Each method has a bounded job
Method families can be configured in many ways. The certificate or laboratory report must state the actual procedure, calculation, units and acceptance criteria.
| Attribute | Possible method family | A suitable result may support | It does not establish alone | Critical limits |
|---|---|---|---|---|
| Identity | Mass spectrometry; specific spectroscopic or chromatographic comparison | Consistency of the sample with the claimed substance under stated criteria | Amount, purity profile, sterility, endotoxin or safety | Specificity, reference, resolution, isomers and fragments |
| Purity profile | High-performance liquid chromatography or another separation method | Relative detected peak profile under the stated conditions | Confirmed identity, mass in the vial or contaminants the detector does not reveal | Detection response, integration, co-elution, reporting threshold and calculation basis |
| Quantity or assay | Validated quantitative chromatographic, spectroscopic or mass-balance procedure | Amount or concentration in the prepared sample, with stated units | Sterility, endotoxin, full identity or clinical effect | Calibration, reference standard, recovery, water or salt basis and uncertainty |
| Sterility | Compendial sterility test or validated alternative | Outcome for viable microorganisms under the test conditions | Absence of endotoxin, viruses, chemical contaminants or future contamination | Sample size, method suitability, incubation and detection probability |
| Endotoxin | Bacterial endotoxins test | Result against a stated endotoxin limit and units | Sterility, identity, purity or all pyrogenic substances | Interference, dilution, units and product-specific limit |
| Residual solvents | Gas chromatography or another targeted procedure | Named solvents within method capability | Unknown or untargeted contaminants | Target list, reporting limits, preparation and matrix effects |
| Elemental impurities | Element-specific mass spectrometry or spectroscopy | Named elements at reported levels | Organic impurities, microorganisms or identity | Target elements, digestion, contamination control and quantitation limits |
Interpretation controls
Four limits travel with every result
01
Measurand
The precise quantity or attribute the procedure intends to measure.
02
Sample
The material actually received, prepared and analysed by the laboratory.
03
Detection
What the method can distinguish or quantify under its operating conditions.
04
Uncertainty
The range and sources of doubt around sampling and measurement.
Detection limits and uncertainty explain why “not detected” means below a method threshold rather than confirmed absence.
nFrequent misreading
Why a high purity percentage is not a complete product result
A chromatographic purity percentage often represents the main peak's area relative to the total integrated peak area seen under stated conditions. It may be useful for comparing the detected profile. It is not automatically the percentage of the vial's mass that is the claimed peptide.
Different compounds can produce different detector responses. Some material may not be detected by the chosen conditions. Water, counterions, excipients and non-absorbing contaminants may sit outside the reported area calculation. Co-eluting components may appear as one peak.
Identity requires suitable confirmation. Quantity requires a validated quantitative procedure with calibration and units. Read purity methods in detail, identity confirmation in detail and assay and quantity in detail.
Separate safety questions
Chemical analysis does not clear microbiological risk
Identity, chromatographic purity and quantity results do not establish sterility or endotoxin status. Those attributes need their own procedures, samples, limits and reports.
Bacterial endotoxins
An endotoxin result needs stated units, limit and interference control. A sterile result does not substitute for it.
Unresolved risk stays unresolved
If the relevant attribute was not measured, the certificate cannot convert that absence into reassurance.
Read sterility and endotoxin in detail and compare residues and contaminants in detail.
Sample representativeness
The laboratory result stops at the tested sample
A result belongs first to the material the laboratory received. Extending it to a production batch requires a defensible sampling plan and traceable batch relationship. Extending it to a consumer-held vial also requires an exact batch match and a coherent custody history.
Sampling can contribute materially to measurement uncertainty. Seller-selected, unsealed or unidentified samples may answer a narrower question than independently purchased, sealed and documented units.
See what independent testing adds and why sample provenance decides the value.
Scope ladder
- Strongest direct statement
- The measured result for the analysed portion
- Needs sampling evidence
- A claim about the submitted sample or batch
- Needs physical matching
- A claim about a particular vial
- Not an analytical conclusion
- Clinical safety or effectiveness in a person
Official basis
Fitness for purpose controls the conclusion
ICH Q2(R2) describes validation as demonstrating that an analytical procedure is fit for its intended purpose. The relevant performance characteristics depend on what the procedure is meant to establish. This supports a disciplined reading: do not expand a result beyond the validated analytical objective.
Eurachem treats sampling as part of the measurement process and explains how it contributes to uncertainty. WHO good manufacturing practice guidance describes detailed laboratory records linking samples, methods, raw data, calculations, results and review to a batch record.
- ICH Q2(R2) validation of analytical procedures · final guideline text hosted by FDA.
- Eurachem: measurement uncertainty arising from sampling · sampling effects and whole-process uncertainty.
- USP: bacterial endotoxins · harmonised compendial method context.
- WHO GMP for active pharmaceutical ingredients · laboratory documentation and batch traceability.
Consumer test-kit boundary
A home or consumer kit cannot substitute for a validated laboratory procedure when identity, quantity, sterility, endotoxin or low-level contaminants are at issue. Read why consumer test kits cannot substitute.
Editorial method: We record method, measurand, sample, detection limit, uncertainty and excluded attributes before writing a result sentence. Sources checked 7 August 2026.
Follow the unresolved attribute
PurityWhat a purity result meansRead chromatography, peak area and calculation limits.
IdentityHow identity is confirmedUnderstand specificity, reference comparisons and method limits.
QuantityAssay and vial contentSeparate relative purity from a quantitative result.
Unchecked attributeWhat happens when a test is missingCarry the uncertainty into the safety conclusion.
Editorial experience
From our work: how we checked this page
For topical-map item C-024, What peptide tests can and cannot prove was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 4 unique external sources and 13 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.